- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
19
Stocks where the price continues to rise after more than a year of consistent gains.
19 companies
AtaiBeckley
Market Cap: US$2.7b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.
ATAI
US$7.22
7D
39.7%
1Y
123.5%
CareDx
Market Cap: US$2.1b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$39.73
7D
39.4%
1Y
233.4%
Harbin Pharmaceutical Group
Market Cap: CN¥13.4b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥5.33
7D
58.2%
1Y
34.9%
Anhui Wanbang Pharmaceutical TechnologyLtd
Market Cap: CN¥6.2b
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
301520
CN¥66.62
7D
47.5%
1Y
101.8%
ACRO Biomedical
Market Cap: NT$18.6b
Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.
6748
NT$261.00
7D
40.3%
1Y
329.3%
Valerio Therapeutics Société anonyme
Market Cap: €304.7m
A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.
ALVIO
€0.61
7D
35.6%
1Y
1,017.2%
Q32 Bio
Market Cap: US$255.2m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$15.05
7D
34.3%
1Y
585.6%
GlaxoSmithKlineE
Market Cap: ج.م8.8b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م105.70
7D
43.6%
1Y
138.6%
October PharmaE
Market Cap: ج.م5.1b
Manufactures and sells pharmaceutical products in Egypt.
OCPH
ج.م427.93
7D
20.5%
1Y
243.3%
Great Novel Therapeutics Biotech & Medicals
Market Cap: NT$2.9b
Engages in the development of drugs for the treatment of advanced and refractory cancers in Taiwan.
7427
NT$67.40
7D
37.3%
1Y
77.4%
New Green Hemp
Market Cap: US$48.5m
New Green Hemp Inc. cultivates and sells hemp products.
NGHI
US$1.92
7D
28.9%
1Y
148.5%
Emyria
Market Cap: AU$39.5m
Engages in delivering and developing of treatments for mental health and select neurological conditions in Australia.
EMD
AU$0.049
7D
28.9%
1Y
40.0%
BetterLife Pharma
Market Cap: US$26.1m
A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.
BETR.F
US$0.16
7D
21.8%
1Y
124.5%
Vectorite Biomedical
Market Cap: NT$669.7m
Engages in the research and development of biotechnology in Taiwan and internationally.
4170
NT$15.30
7D
20.9%
1Y
23.4%
Numinus Wellness
Market Cap: US$12.5m
Provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States.
NUMI.F
US$0.039
7D
29.6%
1Y
65.3%
Stem Cells Spin
Market Cap: zł20.7m
Operates as a biotechnology company in Poland.
SCS
zł0.50
7D
33.7%
1Y
89.4%
Blueberries Medical
Market Cap: CA$7.4m
A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.
BBM
CA$0.015
7D
50.0%
1Y
50.0%
Innovation Pharmaceuticals
Market Cap: US$1.6m
A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.
IPIX
US$0.003
7D
900.0%
1Y
900.0%
OWC Pharmaceutical Research
Market Cap: US$5.0k
Through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products.
OWCP
US$0.00001
7D
900.0%
1Y
900.0%